The PharmaTox Strategic Research Initiative aims to generate novel insight on effects of pharmaceuticals on human neurotoxicity and neurodevelopment.
PharmaTox was established January 1st 2015 as a prioritized research initiative supported by the Faculty of Mathematics and Natural Sciences.
The research projects within PharmaTox involve specialists in neurotoxicology, pharmacology, teratology, statistics, bioinformatics, epigenetics and epidemiology.
Feb. 12, 2019 10:44 AM
Read an interview with Ragnhild Eskeland about her research on Epigenetics.
PharmaTox member awarded travel grants
Jan. 10, 2019 11:43 AM
PharmaTox Postdoc Mussie Ghezu Hadera have been awarded three travel grants. Congratulations!
Wonderful news – PharmaTox 2.0 funded!
Dec. 18, 2018 2:10 PM
Prof. Nordeng appointed by European Commission as independent scientific expert in PRAC
Dec. 4, 2018 1:55 PM
The Pharmacovigilance Risk Assessment Committee (PRAC) is the European Medicines Agency's (EMA) committee responsible for assessing and monitoring the safety of human medicines.
Successful UiO:LifeScience projects in PharmaTox!
Nov. 23, 2018 12:03 PM